126 related articles for article (PubMed ID: 2064275)
1. Low incidence of point mutation at codon 12 of K-ras proto-oncogene in squamous cell carcinoma of the upper aerodigestive tract.
Hirano T; Steele PE; Gluckman JL
Ann Otol Rhinol Laryngol; 1991 Jul; 100(7):597-9. PubMed ID: 2064275
[TBL] [Abstract][Full Text] [Related]
2. [Incidence of point mutations in Ki-ras codon 12 and 13 in squamous epithelial carcinomas of the head-neck region].
Rathcke IO; Gottschlich S; Görögh T; Lippert BM; Werner JA
Laryngorhinootologie; 1996 Aug; 75(8):465-70. PubMed ID: 8962608
[TBL] [Abstract][Full Text] [Related]
3. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
4. K-ras gene point mutation: a stable tumor marker in non-small cell lung carcinoma.
Li S; Rosell R; Urban A; Font A; Ariza A; Armengol P; Abad A; Navas JJ; Monzo M
Lung Cancer; 1994 Jul; 11(1-2):19-27. PubMed ID: 8081702
[TBL] [Abstract][Full Text] [Related]
5. [Detection of G-T mutations at codon 12 of c-Ha-ras oncogenes in squamous cell carcinomas of the sinus maxillaris].
Liu XF
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1992; 27(6):345-7, 382. PubMed ID: 1303668
[TBL] [Abstract][Full Text] [Related]
6. [Studies on ras P21 expression and mutation at 12th codon of C-Ha-ras oncogene in squamous cell carcinoma of the larynx].
Yang Q
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1993; 28(4):209-12, 251. PubMed ID: 8167038
[TBL] [Abstract][Full Text] [Related]
7. Analysis of C-Ha-ras gene amplification and mutation in laryngeal carcinoma.
Liu S; Lin D; Hong B; Huang G
Chin Med Sci J; 1995 Mar; 10(1):59-60. PubMed ID: 7780122
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers.
Matthias C; Bockmühl U; Jahnke V; Jones PW; Hayes JD; Alldersea J; Gilford J; Bailey L; Bath J; Worrall SF; Hand P; Fryer AA; Strange RC
Pharmacogenetics; 1998 Apr; 8(2):91-100. PubMed ID: 10022746
[TBL] [Abstract][Full Text] [Related]
10. Point mutations in the Ha-ras oncogene are detectable in formalin-fixed tissues of oral squamous cell carcinomas, but are infrequent in British cases.
Warnakulasuriya KA; Chang SE; Johnson NW
J Oral Pathol Med; 1992 May; 21(5):225-9. PubMed ID: 1403838
[TBL] [Abstract][Full Text] [Related]
11. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
12. Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.
Shidara K; Suzuki T; Hara F; Nakajima T
Laryngoscope; 1994 Aug; 104(8 Pt 1):1008-12. PubMed ID: 8052064
[TBL] [Abstract][Full Text] [Related]
13. Mutations of Ki-ras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan.
Kuo MY; Jeng JH; Chiang CP; Hahn LJ
J Oral Pathol Med; 1994 Feb; 23(2):70-4. PubMed ID: 8164156
[TBL] [Abstract][Full Text] [Related]
14. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
[TBL] [Abstract][Full Text] [Related]
15. [Point mutation of c-Ha-ras oncogene in oral cancers].
Liu XF
Zhonghua Kou Qiang Yi Xue Za Zhi; 1991 Nov; 26(6):326-8, 388. PubMed ID: 1820236
[TBL] [Abstract][Full Text] [Related]
16. Point mutations of c-ras genes in human bladder cancer and kidney cancer.
Nagata Y; Abe M; Kobayashi K; Saiki S; Kotake T; Yoshikawa K; Ueda R; Nakayama E; Shiku H
Jpn J Cancer Res; 1990 Jan; 81(1):22-7. PubMed ID: 2108944
[TBL] [Abstract][Full Text] [Related]
17. Mutational status of codons 12 and 13 of the N- and K-ras genes in tissue and cell lines derived from primary and metastatic prostate carcinomas.
Pergolizzi RG; Kreis W; Rottach C; Susin M; Broome JD
Cancer Invest; 1993; 11(1):25-32. PubMed ID: 7678540
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma.
Tsuda H; Hirohashi S; Shimosato Y; Ino Y; Yoshida T; Terada M
Jpn J Cancer Res; 1989 Mar; 80(3):196-9. PubMed ID: 2542205
[TBL] [Abstract][Full Text] [Related]
19. Studies on ras oncogene activation in endometrial carcinoma.
Fujimoto I; Shimizu Y; Hirai Y; Chen JT; Teshima H; Hasumi K; Masubuchi K; Takahashi M
Gynecol Oncol; 1993 Feb; 48(2):196-202. PubMed ID: 8428691
[TBL] [Abstract][Full Text] [Related]
20. High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India.
Saranath D; Chang SE; Bhoite LT; Panchal RG; Kerr IB; Mehta AR; Johnson NW; Deo MG
Br J Cancer; 1991 Apr; 63(4):573-8. PubMed ID: 2021541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
